See all results

Coronavirus (COVID-19) Updates

For the latest COVID-19 information and updates from Qatar Foundation, please visit our Statements page

April 19, 2017

Sidra Hosts CUDOS 2017

Sidra Medical and Research Center (Sidra) recently concluded CUDOS 2017 (10-12 April) - its first conference dedicated to understanding the genetic causes of complex diseases such as cardiovascular disease, diabetes, obesity and strokes. The three day conference and workshop, sponsored by the Qatar National Research Fund, featured expert local and international speakers who shared the latest trends, developments and treatment options for these common diseases.
Delegates at CUDOS 2017.JPG
Conference organizer, Dr. Ammira S. Akil, Staff Scientist from the Department of Translational Medicine at Sidra said, “As a health and research facility, Sidra is committed to its goal to offer personalized treatment and care for the women and children of Qatar. The aim of CUDOS 2017 was to create an engaging and productive platform on how to tackle and treat common diseases like obesity, strokes, diabetes and cardiovascular diseases as well as focus on understanding the underlying genetic causes. We want to raise awareness in Qatar and the global scientific community that a lot of local and even international health challenges can be addressed and diagnosed through joint dialogue and collaboration.”
Dr. Ammira Akil opens CUDOS 2017.JPG
Key sessions during the conference included updates related the National Diabetes Strategy of Qatar, new trends in diabetes therapy, clinical trials on diabetes, genetics, epigenetics and the environmental predisposition of type 2 diabetes. Other topics included the nutritional programming of health and diseases as well as molecular biomarkers and clinical studies about type 1 diabetes.
Dr. Ena Wang, Acting Chief Research Officer at Sidra said, “Sidra’s genomic and translational research functions are rapidly merging. We have already established active collaborations with our clinical colleagues on evaluating personalized therapies and treatment options for patients. The dialogue that we are having today at symposiums like CUDOS 2017, is the building block that can result in actual life changing and lifesaving measures for patients coming to Sidra and for other healthcare partners and providers.”

As a follow up to CUDOS 2017, plans are already underway to integrate several partnership and cross-sectorial communication programs with local and international health, research and educational institutions. Sidra is also prioritizing detailed studies in high-risk populations and individuals to identify environmental determinants and triggers prior to multi-population diseases.

For the full story, please click here.